美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件: 药品名称=CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
符合检索条件的记录共6
1 页 当前第 1 页  返回检索页
1药品名称CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
申请号075502产品号001
活性成分BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE市场状态处方药
剂型或给药途径CREAM;TOPICAL规格EQ 0.05% BASE;1%
治疗等效代码AB参比药物
批准日期2001/06/05申请机构FOUGERA PHARMACEUTICALS INC
2药品名称CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
申请号075673产品号001
活性成分BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE市场状态处方药
剂型或给药途径CREAM;TOPICAL规格EQ 0.05% BASE;1%
治疗等效代码AB参比药物
批准日期2001/05/29申请机构TARO PHARMACEUTICALS USA INC
3药品名称CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
申请号076002产品号001
活性成分BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE市场状态处方药
剂型或给药途径CREAM;TOPICAL规格EQ 0.05% BASE;1%
治疗等效代码AB参比药物
批准日期2002/08/02申请机构ACTAVIS MID ATLANTIC LLC
4药品名称CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
申请号076493产品号001
活性成分BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE市场状态处方药
剂型或给药途径LOTION;TOPICAL规格EQ 0.05% BASE;1%
治疗等效代码AB参比药物
批准日期2004/07/28申请机构TARO PHARMACEUTICALS USA INC
5药品名称CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
申请号076516产品号001
活性成分BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE市场状态处方药
剂型或给药途径LOTION;TOPICAL规格EQ 0.05% BASE;1%
治疗等效代码AB参比药物
批准日期2005/06/16申请机构FOUGERA PHARMACEUTICALS INC
6药品名称CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
申请号202894产品号001
活性成分BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE市场状态处方药
剂型或给药途径CREAM;TOPICAL规格EQ 0.05% BASE;1%
治疗等效代码AB参比药物
批准日期2015/10/30申请机构GLENMARK PHARMACEUTICALS SA